Differentiating between myelodysplastic syndromes (MDS) and other causes of cytopenias in a primary care setting primarily involves recognizing suspicious features and ruling out more common, benign causes before considering referral for specialist investigation NICE NG12,NICE CKS. MDS is a group of clonal disorders of haematopoietic stem cells characterized by ineffective haematopoiesis and peripheral cytopenias, which can affect one or more cell lines (anaemia, neutropenia, thrombocytopenia) Foran & Shammo 2012.
In primary care, the initial step for unexplained cytopenias is to perform a full blood count (FBC) NICE NG12,NICE CKS. Key indicators that may raise suspicion for MDS or other haematological cancers include:
- Persistent unexplained cytopenias affecting one or more cell lines, such as anaemia, neutropenia, or thrombocytopenia NICE NG12,NICE CKS. MDS often presents with anaemia, but can also involve isolated neutropenia or thrombocytopenia, or a combination Foran & Shammo 2012.
- Abnormal white cell count, particularly unexplained neutropenia NICE NG12,NICE CKS.
- Unexplained bruising or bleeding, which could indicate thrombocytopenia NICE NG12,NICE CKS.
- Persistent unexplained fatigue, a common symptom of anaemia NICE NG12,NICE CKS.
- The presence of other systemic symptoms like unexplained weight loss, fever, night sweats, or lymphadenopathy, although these are less specific to MDS and can indicate other haematological malignancies NICE NG12,NICE CKS.
- Splenomegaly, which may be present in some cases of MDS, though it is more common in other myeloproliferative neoplasms Foran & Shammo 2012.
Before considering referral for suspected MDS, it is important to investigate and exclude other common causes of cytopenias, which include:
- Nutritional deficiencies (e.g., vitamin B12 or folate deficiency) NICE CKS,NICE CKS.
- Drug-induced cytopenias NICE CKS,NICE CKS.
- Chronic diseases (e.g., chronic kidney disease, liver disease, inflammatory conditions) NICE CKS,NICE CKS.
- Infections NICE CKS,NICE CKS.
- Autoimmune conditions NICE CKS,NICE CKS.
If, after initial investigations, the cytopenias remain unexplained or there are features suggestive of a haematological malignancy, the patient should be referred for a suspected cancer pathway, typically to a haematologist NICE NG12,NICE CKS. Definitive diagnosis of MDS requires a bone marrow examination, which is performed in secondary care Foran & Shammo 2012.
Key References
- CKS - Platelets - abnormal counts and cancer
- NG12 - Suspected cancer: recognition and referral
- CKS - Multiple myeloma
- CKS - Haematological cancers - recognition and referral
- CKS - Erythrocytosis/polycythaemia
- (Foran and Shammo, 2012): Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes.